Sort by:
53 products
53 products
DRAMAMINE 50 mg - Antiemetic and Anti-motion Sickness Tablets
DRAMAMINE is a tablet containing dimenhydrinate, an antihistamine with antiemetic properties. Presented in a box with 24 tablets from Johnson & Johnson laboratories, it is the go-to option for conveniently and reliably preventing and relieving motion sickness, nausea, and vomiting associated with movement (kinetosis).
🌿 Active ingredient:
Dimenhydrinate (50 mg per tablet): An antihistamine that blocks H1 receptors in the vestibular system and the vomiting center, reducing the impulses that cause motion sickness, nausea, and vomiting.
✨ Benefits:
Prevents and relieves motion sickness (kinetosis) when traveling by car, plane, boat, or train.
Reduces nausea and vomiting associated with movement quickly and effectively.
Trusted brand formula with over 70 years of clinical backing.
📦 How to use: Take 1 tablet 30 minutes before travel or as directed on the package. Do not exceed the recommended dose. Consult your doctor if you have any questions.
The consumption of this product is the responsibility of those who recommend and use it. Consult your doctor before consuming any medication.
PEPTO-BISMOL 262.4 MG ANISE FLAVOR 24 CHEWABLE TABLETS
PEPTO-BISMOL is the world's trusted antacid and gastric protector, now in a presentation of 24 chewable tablets with a 262.4 mg anise flavor. Its bismuth subsalicylate formula offers fast and complete relief from the main digestive discomforts in a practical and delicious format.
🌿 Active ingredient:
-
Bismuth subsalicylate 262.4 mg: Main active ingredient that protects and coats the gastric and intestinal lining, neutralizes toxins, and reduces inflammation of the digestive tract for quick and effective relief.
✨ Benefits:
-
Fast relief from heartburn, acid indigestion, and upset stomach, protecting the gastric lining.
-
Effectively combats diarrhea, nausea, and stomach upset of digestive origin.
-
Available in 24 anise-flavored chewable tablets, practical and pleasant-tasting for relief anytime.
📦 How to use: Chew tablets completely before swallowing. Consume according to package directions. Do not exceed the recommended dose.
The consumption of this product is the responsibility of those who recommend and use it. Consult your doctor before consuming any medication.
DIFENIDOL (VONTROL) 25 mg
Comparable to: Vontrol
Active substance: Difenidol
Concentration: 25 mg per tablet
Presentation: Box with 30 tablets
Laboratory: N/A
Origin: Made in Mexico
This medication is an antivertigo and antiemetic agent indicated for the control of vertigo, nausea, and vomiting associated with inner ear disorders, Meniere's disease, labyrinthitis, and other vestibular alterations. It acts by inhibiting the vomiting reflex and reducing the sensation of dizziness and imbalance.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
SERRATOL (DIFENIDOL) 25 mg
Comparable to: Vontrol
Active ingredient: Difenidol
Concentration: 25 mg per tablet
Presentation: Box with 30 tablets
Laboratory: N/A
Origin: Made in Mexico
This medication is an antivertigo and antiemetic agent indicated for the control of vertigo, nausea, and vomiting associated with inner ear disorders, Meniere's disease, labyrinthitis, and other vestibular alterations. It acts by inhibiting the vomiting reflex and reducing the sensation of dizziness and imbalance.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medicine.
DIFENIDOL 40 mg/2 mL Injectable Solution
Comparable to: Vontrol Injectable
Active substance: Diphenidol (Diphenidol hydrochloride)
Concentration: 40 mg per 2 mL ampoule
Presentation: Box with 2 x 2 mL ampoules
Laboratory: Laboratorios PiSA
Origin: Made in Mexico
This antivertigo and antiemetic medication is used for the treatment of peripheral vertigo, nausea, and vomiting of various causes. It works by inhibiting nerve impulses from the inner ear labyrinth, reducing sensations of dizziness and associated discomfort, providing rapid and effective relief via injectable administration.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
CARNOTPRIM (METOCLOPRAMIDE) 10 mg
Comparable to: Carnotprim
Active substance: Metoclopramide
Concentration: 10 mg per tablet
Presentation: Box with 20 tablets
Laboratory: Carnot
Origin: Mexico
This medication is used for the treatment of nausea and vomiting of various causes, as well as in the management of gastrointestinal motility disorders, as metoclopramide helps to accelerate stomach emptying and promotes intestinal movement.
The consumption of this product is the responsibility of those who recommend and use it. Consult your doctor before consuming any medication.
Gastrointestinal Disorders: gastroesophageal reflux, infectious gastroenteritis, gastric ulcer, pyloric stenosis, chronic primitive intestinal pseudo-obstructions.
Iatrogenic gastroparesis: To counteract the effects of the use of anticholinergics, opiates, dopaminergics.
Surgical sequelae: Vagotomy with pyloroplasty, fundic vagotomy, partial gastrectomies.
Psychic and neuromuscular disorders: Anorexia nervosa, amyloidosis, collagenopathies, scleroderma, muscular dystrophies (spastic colon), various neuropsychiatric syndromes.
Metabolic and endocrine disorders: diabetes, hypothyroidism, renal failure.
In acute or chronic vomiting, of gastroenterological, infectious, metabolic, endocrine, neurological, iatrogenic, psychogenic, anatomical, respiratory etiology.
Prophylactic utility in nausea and/or vomiting caused by: Chemotherapy, radiotherapy, perianesthesia, motion sickness, etc.
Of analgesic utility due to central action (alone or in interaction): As an aid in headaches of vascular origin (migraine).
Useful in the induction of lactation. An aid when lactation needs to be induced.
CONTRAINDICATIONS: Hypersensitivity to metoclopramide. Intestinal obstruction, perforation, or any other condition in which increased gastrointestinal motility is risky. Acute appendicitis, extrapyramidal syndrome.
GENERAL PRECAUTIONS: When metoclopramide is administered concomitantly with psychotropics, antihistamines, or barbiturates, it should be noted that it may produce additional depressive effects on the CNS, likewise when alcohol is consumed concomitantly with the medication.
When the parenteral route is used, if the medication is administered rapidly, extrapyramidal symptoms (torticollis, trismus, oculogyric crises) may occur, which are reversible upon discontinuation of the medication or subside with the administration of diazepam or diphenhydramine. In international literature, the appearance of extrapyramidal symptoms with the administration of metoclopramide at therapeutic doses is 1 in 33,000 patients.
In patients with chronic renal failure, the administration of the drug for prolonged periods should be evaluated, because its elimination is renal in 98% of cases, and if necessary, the dose of the medication will be adjusted.
RESTRICTIONS ON USE DURING PREGNANCY AND LACTATION: Metoclopramide has been widely used during pregnancy to relieve hyperemesis gravidarum, gastroesophageal reflux, and gastroparesis that may occur during pregnancy.
The general consensus recommends its use during the second and third trimesters of pregnancy, and as with the vast majority of medications not contraindicated during pregnancy, its prescription during the first trimester is left to the discretion of the treating physician, taking into account the severity of the case, the potential benefits and the probable risk that there might be for the product.
Metoclopramide is eliminated in small doses in breast milk (see Dosage and Administration).
CARNOTPRIM Tablets 10 mg: (gastroprokinetic, antiemetic, gastroesophageal reflux, anti-migraine).
Children 6 to 12 years: ½ tablet (5 mg) 3 times daily before meals.
Over 12 years or over 40 kg:
1 tablet 3 or 4 times daily before meals.
CARNOTPRIM Tablets 10 mg: (gastroprokinetic, antiemetic, anti-migraine, assist in the induction of lactation).
Adults and children over 40 kg: 1 tablet 3 or 4 times daily before meals.
Induction of lactation: 1 tablet every 8 hours, depending on the response of the patient, for a maximum period of 10 days.
CIRULAN (METOCLOPRAMIDE) 10 mg
Comparable to: Cirulan
Active ingredient: Metoclopramide
Concentration: 10 mg per tablet
Presentation: Box with 20 tablets
Laboratory: Novag
Origin: Mexico
This medication is used for the treatment of nausea and vomiting of various causes, as well as in the management of gastrointestinal motility disorders, as metoclopramide helps to accelerate stomach emptying and promotes intestinal movement.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
Gastrointestinal Disorders: gastroesophageal reflux, infectious gastroenteritis, gastric ulcer, pyloric stenosis, chronic intestinal pseudo-primitive.
Iatrogenic gastroparesis: To counteract the effects of the use of anticholinergics, opiates, dopamine.
Surgical sequelae: Vagotomy with pyloroplasty fundic vagotomy, partial gastrectomy.
Psychic and neuromuscular disorders: Anorexia nervosa, amyloidosis, collagen diseases, scleroderma, muscular dystrophy (spastic colon), various neuropsychiatric syndromes.
Metabolic and endocrine disorders: diabetes, hypothyroidism, renal failure.
In acute or chronic vomiting, etiology, gastroenterology, infectious, metabolic, endocrine, neurological, iatrogenic, psychogenic, anatomical breathing.
Prophylactic utility nausea and / or vomiting from chemotherapy, radiotherapy, PeriAnesthesia, travel sickness, etc..
Useful for centrally acting analgesic (alone or in interaction): As an aid in vascular headaches (migraine).
Useful in the induction of lactation. Assistant when required to induce lactation.
Hypersensitivity to metoclopramide. Intestinal obstruction, perforation or any other condition in which increased gastrointestinal motility is risky. Acute appendicitis, extrapyramidal syndrome.
CAUTIONS: When administered metoclopramide in conjunction with psychotropic drugs, antihistamines, or barbiturates, it should be noted that additional depressive effect may occur in the CNS, also when alcohol is consumed concurrently with the drug.
When you use the injectors, if the medicine is applied quickly can even cause extrapyramidal symptoms (torticollis, trismus, oculogyric crisis), which are reversible after discontinuation of the drug or give in to the administration of diazepam or diphenhydramine. In the international literature, the emergence of extrapyramidal symptoms with metoclopramide at therapeutic doses is 1 in 33,000 patients.
In patients with chronic renal failure should be evaluated drug administration for prolonged periods, because their elimination is via the kidneys in 98% and, if necessary, adjust the dose of medication.
DOSAGE AND ADMINISTRATION: Oral.
CARNOTPRIM Tablets 10 mg (gastroprokinetic, antiemetic, gastroesophageal reflux disease, migraine).
Children 6 to 12 years: ½ tablet (5 mg) 3 times daily before meals.
Over 12 years or over 40 kg:
1 tablet 3 or 4 times daily before meals.
CARNOTPRIM Tablets 10 mg (gastroprokinetic, antiemetics, antimigraine, assist in the induction of lactation).
Adults and children over 40 kg: 1 tablet 3 or 4 times daily before meals.
Induction of lactation: 1 tablet every 8 hours, depending on the response of the patient, for a maximum period of 10 days
MOTILIUM (DOMPERIDONE) 10 mg
Comparable to: Motilium
Active ingredient: Domperidone
Concentration: 10 mg per tablet
Presentation: Box with 30 tablets
Laboratory: JANSSEN-CILAG
Origin: Mexico
This medicine is used for the treatment of nausea, vomiting, and symptoms of slow gastrointestinal motility (such as feeling of fullness, bloating, and post-prandial discomfort). Domperidone works by increasing stomach and intestinal movement, facilitating digestion and reducing nausea.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
- Feeling at epigastric fullness, early satiety, feeling of abdominal distention, upper abdominal pain.
- Belching, flatulence.
- Nausea and vomiting.
- Heartburn with or without regurgitation of gastric contents into the mouth.
- Nausea and vomiting of functional origin, organic, infectious or dietetic or induced by radiation therapy or pharmacotherapy.
A specific indication is nausea and vomiting induced by dopamine agonists, such as those used in Parkinson's disease (such as L-dopa and bromocriptine).
CONTRAINDICATIONS: Motilium ® is contraindicated in the following situations:
Known hypersensitivity to domperidone or any of its excipients.
Prolactin-releasing pituitary tumor (prolactinoma).
Coadministration with oral ketoconazole, erythromycin, or other potent CYP3A4 inhibitors that prolong the QTc interval such as fluconazole, voriconazole, clarithromycin, amiodarone, and telithromycin.
Motilium ® should not be used in cases in which the stimulation of gastric motility might be dangerous, for example, gastrointestinal hemorrhage, mechanical obstruction or perforation.
CAUTIONS: When using antacids or antisecretory agents, concomitantly, they should be administered after meals and not before them, ie should not be administered simultaneously with the tablets and suspension Motilium ®.
Use Precautions: Enteric coated tablets contain lactose and may be unsuitable for patients with lactose intolerance, galactosemia, or malabsorption of glucose / galactose.
The oral suspension contains sorbitol and may be inadequate for patients intolerant to sorbitol.
Use in children: Because the metabolic and blood-brain barrier are not fully developed during the first months of life, Motilium ® as well as any medication that is administered to infants younger, should be used with caution and under close supervision care.
Since the typical absence of neurological side effects Motilium ® is due to the limited penetration through the blood brain barrier, the occurrence of these effects can not be totally excluded in babies under 1 year.
Use in hepatic impairment: Since domperidone is extensively metabolized in the liver, Motilium ® should be used with caution in patients with liver damage.
Use in renal impairment: In patients with severe renal insufficiency (serum creatinine> 6 mg/100 ml, for example,> 0.6 mmol / l) elimination half-life of domperidone is increased from 7.4 to 20.8 hours but plasma levels are lower than in healthy volunteers. Since a small amount of the drug is excreted by the kidneys, it is unlikely that the dose of a single acute dose needs to be adjusted in patients with renal failure. However, with repeated administration, frequency of administration should be reduced to once or twice daily depending on the severity of damage, and may also be necessary to reduce the dose.
Generally, patients with prolonged therapy should be reviewed regularly.
Effects on ability or use machines: Motilium ® does not affect mental alertness.
RESTRICTIONS OF USE DURING PREGNANCY AND LACTATION:
Use in pregnancy: There are limited post-marketing data on the use of domperidone in pregnant women. A study in rats has shown reproductive toxicity at high doses, is toxic to the mother. No one knows the potential risk to humans. Therefore, Motilium ® should be used during pregnancy only where justified by the anticipated therapeutic benefit.
Adults and adolescents (over 12 years and weighing 35 kg or more):
Tablets: 1 to 2 tablets of 10 mg three to four times a day, with a maximum daily dose of 80 mg.
Vylkor 8 mg
Comparable to: Zofran
Active ingredient: Ondansetron
Concentration: 8 mg per tablet
Presentation: Box with 10 tablets
Laboratory: RAAM
Origin: Made in Mexico
This medication is used for the prevention and treatment of nausea and vomiting, especially those associated with chemotherapy, radiotherapy, and surgical procedures. It works by blocking the action of serotonin, a substance that can trigger the vomiting reflex.
The consumption of this product is the responsibility of those who recommend it and those who use it. Consult your doctor before consuming any medication.
VO-REMI (MECLIZINE / PYRIDOXINE)
Comparable to: VO-REMI
Active ingredient: Meclizine / Pyridoxine
Concentration: 25 mg / 50 mg
Presentation: Box with 12 tablets
Laboratory: Son's
Origin: Mexico
VO-REMI is a medication indicated for the prevention and treatment of nausea, vomiting, and vertigo associated with balance disorders, motion sickness, and vestibular alterations. Meclizine acts as an antiemetic and antivertigo agent, while pyridoxine (vitamin B6) contributes to the control of nausea.
The consumption of this product is the responsibility of those who recommend and use it. Consult your doctor before consuming any medication.
BONADOXINA (MECLIZINE / PYRIDOXINE)
Comparable to: Bonadoxina
Active ingredient: Meclizine / Pyridoxine
Concentration: 25 mg / 50 mg
Presentation: Box with 25 tablets
Laboratory: PFIZER
Origin: Mexico
Bonadoxina is a medication indicated for the prevention and treatment of nausea, vomiting, and vertigo associated with balance disorders, motion sickness, and vestibular alterations. Meclizine acts as an antiemetic and antivertigo agent, while pyridoxine (vitamin B6) helps control nausea.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
Related Products
- Choosing a selection results in a full page refresh.
- Opens in a new window.